Interaction Guide · Research summary

Can I take Melatonin with Imipramine?

Review Melatonin with Imipramine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Ask your prescriber before adding melatonin to imipramine. Prolonged-release melatonin product information reports more tranquility and difficulty performing tasks with the combination.

What this answer covers

Oral imipramine with Circadin prolonged-release melatonin; other formulations and doses have not been shown equivalent.

Supplement or preparation
Melatonin
Medication ingredient
imipramine

The interaction was functional

Circadin information reports increased tranquility and difficulty performing tasks compared with imipramine alone. This supports reviewing daytime alertness and activities.

Drug levels were not significantly changed

The same product information reports no clinically significant pharmacokinetic interaction. Added functional effects do not require claiming that imipramine or melatonin accumulated.

Keep the tested product in view

The evidence concerns prolonged-release melatonin. It does not establish the same effect for every immediate-release dose or provide a protective time gap.

Watch for impaired alertness

Imipramine can affect alertness and coordination. Avoid driving if affected and contact the prescriber if added sleepiness, confusion or unsteadiness appears after a new product. Severe confusion, fainting or inability to wake needs urgent assessment.

Evidence and practical considerations

Side effects & toxicity

Exact co-use label supports a conditional functional-impairment precaution despite no clinically significant PK interaction.

Exact scope
Oral imipramine with Circadin prolonged-release melatonin; other formulations and doses have not been shown equivalent. with Exact oral imipramine hydrochloride tablets. RxNorm IN 5691/PIN 150816 hydrochloride; pamoate capsule is not assumed the same tested formulation. Desipramine metabolite evidence is distinguished from directly prescribed imipramine.
Medication form and route
oral
Timing or duration
Source-specific single-dose, repeated-dose and observational exposures distinguished.

What remains uncertain

  • Original trial is summarized by the product label; detailed protocol and risk magnitude are unavailable.

Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral imipramine.

Exact label warns about anticholinergic and sympathomimetic co-use, alcohol-related CNS effects and MAOI combinations. It does not explicitly name tryptophan, St John’s wort or serotonin syndrome.

How this applies: RxNorm IN 5691/PIN 150816 hydrochloride; pamoate capsule is not assumed the same tested formulation. Desipramine metabolite evidence is distinguished from directly prescribed imipramine.

No universal supplement interval, event rate or preparation equivalence established. Original label distinguishes warnings from measured pair-specific results.

Source 2: official product label

medicines.org.uk · Source check Sep 10, 2026

Population: Participants in original interaction studies summarized by label.

No clinically significant pharmacokinetic interaction; greater tranquility and difficulty performing tasks compared with imipramine alone.

How this applies: Exact imipramine co-use, limited to the prolonged-release melatonin study summarized by the product label.

Label summary lacks full trial detail. Imipramine findings cannot establish desipramine, nortriptyline or trazodone interaction magnitude.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact available claims adjudicated using original captures and explicit identity and comparator limits.
Research summary published

Article revision: f6336db89cc452c7

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.